Rock-Solid Triferic Heads Toward ODAC Review

Rockwell Medical Inc.’s ferric pyrophosphate seems poised to help firm’s emerging dialysis franchise if FDA is comfortable with an imbalance of deaths deemed not related to the drug seen in pivotal trials.